Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
InflaRx
IFRX
$271M
| $2.01M | ﹤0.01% |
648,632
-46,745
| -7% | -$119K |
|
|
NXC
4352
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
| $2.01M | ﹤0.01% |
139,949
+2,118
| +2% | +$28.1K |
|
4353
Miller Industries
MLR
$619M
| $2.01M | ﹤0.01% |
75,285
-16,414
| -18% | -$421K |
|
4354
Invesco Pennsylvania Value Municipal Income Trust
VPV
$200M
| $2M | ﹤0.01% |
204,355
-9,793
| -5% | -$94.8K |
|
|
ETO
4355
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$520M
| $2M | ﹤0.01% |
95,506
-7,227
| -7% | -$155K |
|
|
TSVT
4356
DELISTED
2seventy bio
TSVT
| $2M | ﹤0.01% |
213,099
+154,808
| +266% | +$2.18M |
|
|
ALX
4357
Alexander's
ALX
$1.41B
| $1.99M | ﹤0.01% |
9,043
+3,581
| +66% | +$817K |
|
|
MQT
4358
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $1.99M | ﹤0.01% |
194,536
+2,869
| +1% | +$28.8K |
|
|
AGEN
4359
Agenus
AGEN
$290M
| $1.99M | ﹤0.01% |
42,195
-22,580
| -35% | -$1.15M |
|
4360
Civeo
CVEO
$318M
| $1.97M | ﹤0.01% |
63,371
-10,062
| -14% | -$293K |
|
|
PETQ
4361
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.97M | ﹤0.01% |
213,752
+18,662
| +10% | +$174K |
|
|
GLU
4362
Gabelli Utility & Income Trust
GLU
$116M
| $1.97M | ﹤0.01% |
139,839
-25,046
| -15% | -$358K |
|
|
XHG
4363
XChange TEC
XHG
$50M
| $1.97M | ﹤0.01% |
+50
| New | +$1.39M |
|
4364
Inovio Pharmaceuticals
INO
$69M
| $1.96M | ﹤0.01% |
104,790
-2,948
| -3% | -$66.8K |
|
|
CTLP
4365
DELISTED
Cantaloupe
CTLP
| $1.96M | ﹤0.01% |
450,931
+34,202
| +8% | +$121K |
|
|
ITIC
4366
Investors Title Co
ITIC
$547M
| $1.95M | ﹤0.01% |
13,247
+11,577
| +693% | +$1.68M |
|
4367
Mitek Systems
MITK
$834M
| $1.95M | ﹤0.01% |
201,639
-20,120
| -9% | -$212K |
|
4368
Invesco CurrencyShares Australian Dollar Trust
FXA
$98M
| $1.95M | ﹤0.01% |
28,989
-58,150
| -67% | -$3.78M |
|
|
IMVP
4369
Invesco India ETF
IMVP
$116M
| $1.95M | ﹤0.01% |
91,702
+59,472
| +185% | +$1.44M |
|
|
OLP
4370
One Liberty Properties
OLP
$527M
| $1.95M | ﹤0.01% |
87,815
-2,515
| -3% | -$57.6K |
|
4371
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
| $1.95M | ﹤0.01% |
45,630
-206,603
| -82% | -$8.62M |
|
|
SPNS
4372
DELISTED
Sapiens International
SPNS
| $1.95M | ﹤0.01% |
105,567
+10,751
| +11% | +$202K |
|
|
CRON
4373
Cronos Group
CRON
$1.14B
| $1.95M | ﹤0.01% |
767,896
-345,248
| -31% | -$1.01M |
|
4374
CarParts.com
PRTS
$54.7M
| $1.95M | ﹤0.01% |
31,111
+11,192
| +56% | +$586K |
|
4375
Cytek Biosciences
CTKB
$546M
| $1.94M | ﹤0.01% |
189,585
-25,457
| -12% | -$342K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.